17th Hong Kong International Wine & Spirits Fair opens next month

- Over 620 exhibitors from 21 countries and regions will showcase alcoholic, low-alcohol and non-alcoholic beverages including beer, brandy, Chinese baijiu, Japanese sake, whisky, wine, and vodka,- Inaugural “World of Spirits” zone features spirits from 13 countries and regions, helping international brands go global and tap into new markets, leveraging the opportunities brought by the reduction in liquor duty- Homegrown brands are on the rise, and the Wine and Spirits Fair offers a platform for Hong Kong brands to showcase their creativity and strength while exploring and seizing international market expansion opportunities- The Wine and Spirits Fair continues to host blind tasting sessions led by three experts, who will select a list of their favourite wines and spiritsHONG KONG, Oct 21, 2025 - (ACN Newswire via SeaPRwire.com) – The 17th edition of the Hong Kong International Wine & Spirits Fair (the Wine & Spirits Fair), organised by the Hong Kong Trade Development Council (HKTDC), will be held on 6-8 November at the Hong Kong Convention and Exhibition Centre. The event will showcase beer, sake, spirits, wines, low- and non- alcoholic beverages to industry professionals and buyers. This year, 620 exhibitors from 21 countries and regions will participate, with a significant increase in Chinese baijiu exhibitors. The rise of homegrown brands, combined with fine wines from around the world, highlights Hong Kong’s role as a hub for the wine and spirits trade and meets the market’s demand for diverse alcoholic beverages.With a growing market demand for spirits and the HKSAR Chief Executive’s announcement in last year’s Policy Address regarding the reduction in liquor duty, Hong Kong continues to strengthen its role as an international trade platform, helping spirits brands go global.Jenny Koo, Deputy Executive Director of HKTDC, said: “The reduction of duty on high end liquor had a positive impact on the industry and encouraged diversified development in the spirits market. At this year’s Wine & Spirits Fair, there is a new World of Spirits zone where buyers and visitors can explore the rich variety of flavours of spirits from around the world. Some 20 activities will further promote the diverse development of the spirits market.”Strong exhibitor line-up with global selectionsExhibitors represent Hong Kong and various provinces and cities on the Chinese Mainland, including Fujian, Guizhou, Hubei, Sichuan, Jiangsu, Xinjiang, and Zhejiang (Zhuji) as well as Taiwan. International exhibitors include those from Argentina, Australia, Belarus, Brazil, Chile, Czechia, France, Germany, India, Ireland, Israel, Italy, Japan, Portugal, Russia, South Korea, Spain and the United States.The inaugural “World of Spirits” zone features spirits from 13 countries and regions, including Chinese baijiu, brandy, gin, rum, tequila, vodka and whisky. Chinese baijiu is a highlight, with six of the “Top 10 Chinese Baijiu Brands” participating, including Kweichow Moutai, Jiangsu Yanghe, and Wuliangye, Luzhou Laojiao, Jiannanchun, Langjiu from Sichuan.Kweichow Moutai will showcase its iconic “Flying Fairy” Moutai and the award-winning “Golden Prince” Moutai Prince, which was recognised as a "2024 Annual Golden Case” in Activity Marketing. Luzhou Laojiao, the brand inscribed in the First National Intangible Cultural Heritage List of China, will present a Luzhou Laojiao Antique Edition and Guojiao 1573, and launch a new baijiu on the first day of the Wine & Spirits Fair. Wuliangye and Yanghe demonstrate the trend of integrating innovative technologies into the baijiu industry, aiming for younger and more diverse markets, injecting new energy into the sector.Hong Kong Actor Timmy Hung’s brand Hongjiaban Maotai blends traditional brewing techniques with Hong Kong-style flavours and action movie culture, while strictly following Maotai's ancient brewing methods.Austria’s Martin & Ann Arndorfer Anina Verde, a top-tier Austrian natural wine will be featured in the Wine and Spirits Fair. Italy’s Don Carlo features a unique brewing process that takes over three years, offering a balanced structure and rich layers.Hyakusyun Junmai Daiginjo from Japan uses locally grown “Mino Nishiki” sake rice cultivated through natural farming methods and is unfiltered, preserving its original flavour, aroma, richness, and natural effervescence.With rising demand for low-alcohol beverages, Punch Club OÜ, an Estonian craft cocktail brand, specialises in organic, low-sugar, ready-to-drink cocktails for health-conscious consumers.The Wine & Spirits Fair also features the “Friends of Wine” zone, which showcases gourmet foods designed to complement alcoholic beverages.Spirits-related activities help the industry seize new opportunitiesTo help the spirits industry seize new opportunities in the market, nearly half of this year’s activities are spirits-related, including the 2025 China Baijiu Culture International Promotion Asia Forum, co-hosted by the China Alcoholic Drinks Association and the HKTDC on 6 November. 2025 Hong Kong International Spirits Challenge Awards Ceremony on 7 November, organised by the Hong Kong General Chamber of Wine & Spirits, will honour outstanding Chinese baijiu brands. Tomy Fong, Experienced Chinese Baijiu Connoisseur, will present “Baijiu – The Rising Trend” on the same day to explore the current trends of Chinese Baijiu. Baijiu 101 Class on the last day of the Wine & Spirits Fair, organised by VTC, will also allow the public to experience baijiu culture and tasting methods, and learn about its 12 aroma types.Three Masters of Wine will host several major events: Debra Meiburg will lead the Cathay Global Wine & Spirits Awards Asia Presentation Ceremony, Wine Industry Conference: AI in Wine Business, and Austrian Wine and Local Sauce Pairing Workshop. Jennifer Docherty will share insights in a seminar titled Off the beaten path, gems from unsung regions. Xing Wei will host Tasting Chinese Terroir Wines, and join Carlito Chiu, an award-winning sommelier, along with Calvin Choi, a certified sommelier, in the blind tasting event. They will select their favourite wines and spirits as reference for industry buyers, to be announced on the first of the Fair.Other competitions and food pairing events including HK Best Spirits Awards 2025, Hong Kong International Mixology Showdown 2025 and Mixology Party. Several exciting pairing sessions have been added, including WINE LUXE Hong Kong TOP 10 Wine Pairing Restaurant Awards Presentation Ceremony 2025 on the second day of the Fair and Sake-Chinese Food Pairing on the final day.Public Day welcomes wine loversOn the final day, the “Wine Fiesta” Zone will be open to public ticket holders aged 18 or above to sample and buy a range of wines and spirits, while enjoying wine tasting experiences through several activities. Regular tickets are priced at HK$220, with specially priced tickets at HK$128 available from 22 October to 7 November via CTG Bus, GoByBus, HK Liquor Store, HK01, HKGO, KKDay, KLOOK, lankwaifong.com, Trip.com, Winenow, Wai Shing Wine International CO., Ltd. and Trans-Island Chinalink. Ticket buyers will receive a Lucaris crystal wine glass on a first-come, first-served basis.Photo download: http://bit.ly/3L1lqwSAt the press conference, HKTDC Deputy Executive Director Jenny Koo (centre) announced that the 16th International Wine & Spirits Fair will bring together more than 620 exhibitors from 20 countries and regions Debra Meiburg MW (left), Master of Wine, and Tomy Fong (right), Experienced Baijiu Connoisseur, also analysed industry trends at the press conferenceJenny Koo, HKTDC Deputy Executive Director (front row centre), Debra Meiburg MW, Master of Wine (front row third left), Tomy Fong, Experienced Chinese Baijiu Connoisseur (front row third right) and representatives from consulates and industry organisations attended the 17th HKTDC Hong Kong International Wine & Spirits Fair press conferenceThis year's Wine & Spirits Fair will bring exhibitors from Hong Kong and Chinese Mainland, and overseas exhibitors from around the world.The Wine & Spirits Fair showcases fine wines and spirits from around the world as well as related products and services to trade visitors and buyers, promoting Hong Kong as a regional trading hub for wine and spiritsKweichow Moutai showcases its iconic “Flying Fairy” Moutai and the award-winning “Golden Prince” Moutai PrinceHong Kong Actor Timmy Hung’s brand Hongjiaban Maotai blends traditional brewing techniques with Hong Kong-style flavours and action movie culture, while strictly following Maotai's ancient brewing methods.The champion of the Hong Kong International Mixology Showdown 2024 –HK region, Yvonne from the Hong Kong Jockey Club Clubhouse, created a signature cocktail named “Secret”.The champion of the Hong Kong International Mixology Showdown 2024 – GBA, Kenneth from the Hong Kong Jockey Club Clubhouse, created a signature cocktail named “Harmony”.WebsiteHong Kong International Wine & Spirits Fair: https://www.hktdc.com/event/hkwinefair/enMedia enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department:Katy WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the Chinese Mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.  Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Air T Enters into Agreement with Regional Express Holdings Limited

MINNEAPOLIS, MN, Oct 21, 2025 - (ACN Newswire via SeaPRwire.com) - Air T, Inc. (NASDAQ:AIRT) has entered into a Sale and Implementation Deed (SID) with the Administrators of Regional Express Holdings Limited (Administrators Appointed) and certain of its subsidiaries (Rex), which operates the leading regional airline in Australia. Air T expects to close the acquisition of Rex by year-end if creditor and other approvals are obtained.Air T has been working closely with the Administrators and the Australian Government, Rex's secured lender, to develop a solution that best serves the interests of all stakeholders. To support the implementation of the acquisition, Air T and the Commonwealth of Australia have entered into an agreement pursuant to which Rex's financing arrangements will be restructured in connection with the acquisition.The proposed acquisition contemplates a continuation and growth of Rex's regional airline business and continuing employment for its workforce.Rex plays an essential role in connecting regional Australian communities. Approximately 50% of Rex's routes are not serviced by any other airline. Air T likes the Rex Saab 340 program and will be funding Rex's engine renewal program and returning its fleet to service.Air T will work to ensure Rex will continue to operate on a sustainable basis, thereby providing critical services to regional Australians. Air T believes it was selected to acquire the company in part because of its long-term investment horizon, experience in regional aircraft, and commitment to stabilizing and growing Rex.The transaction remains subject to certain other approvals, including approval by Rex's creditors and the Federal Court of Australia.Further disclosure regarding the implementation of the transaction will be provided as the transaction progresses. Air T remains committed to transparency and will share information about the transaction during this process.About AIR T, INC.Established in 1980, Air T, Inc. is a portfolio of powerful businesses and financial assets, each of which is independent yet interrelated. Its core segments are overnight air cargo, ground support equipment, commercial aircraft, engines and parts, and digital solutions. We seek to expand, strengthen and diversify Air T's after-tax cash flow per share. Our goal is to build Air T's core businesses, and when appropriate, to expand into adjacent and other industries. We seek to activate growth and overcome challenges while delivering meaningful value for all stakeholders. For more information, visit www.airt.com. The information on our website is available for informational purposes only and is not incorporated by reference into this press release.FORWARD-LOOKING STATEMENTSCertain statements in this press release, including those contained in "Overview," are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to the Company's financial condition, results of operations, plans, objectives, future performance and business. Forward-looking statements include those preceded by, followed by or that include the words "believes", "pending", "future", "expects," "anticipates," "estimates," "depends" or similar expressions. These forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by such forward-looking statements, because of, among other things, potential risks and uncertainties, such as:An inability to finance our operations through bank or other financing or through the sale of issuance of debt or equity securities;Economic and industry conditions in the Company's markets;The risk that contracts with FedEx could be terminated or adversely modified;The risk that the number of aircraft operated for FedEx will be reduced;The risk that GGS customers will defer or reduce significant orders for deicing equipment;The impact of any terrorist activities on United States soil or abroad;The Company's ability to manage its cost structure for operating expenses, or unanticipated capital requirements, and match them to shifting customer service requirements and production volume levels;The Company's ability to meet debt service covenants and to refinance existing debt obligations;The risk of injury or other damage arising from accidents involving the Company's overnight air cargo operations, equipment or parts sold and/or services provided;Market acceptance of the Company's commercial and military equipment and services;Competition from other providers of similar equipment and services;Changes in government regulation and technology;Changes in the value of marketable securities held as investments;Mild winter weather conditions reducing the demand for deicing equipment;Market acceptance and operational success of the Company's commercial jet engines and parts segment or its aircraft asset management business and related aircraft capital joint venture; andDespite our current indebtedness levels, we and our subsidiaries may still be able to incur substantially more debt, which could further exacerbate the risks associated with our substantial leverage.A forward-looking statement is neither a prediction nor a guarantee of future events or circumstances, and those future events or circumstances may not occur. We are under no obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise.CONTACTTracy KennedyChief Financial Officer704-264-5102SOURCE: Air T, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

退休人士可靠的股息股票

(SeaPRwire) -   对于寻求稳定收入来源的退休人士来说,股息股票可能是一个有吸引力的选择。在这方面,有两家公司脱颖而出,它们是AT&T (NYSE:T)和Procter & Gamble (NYSE:PG)。这两家公司在提供可靠股息方面拥有悠久的历史,使其成为那些希望确保财务未来的人的有吸引力的选择。 AT&T是一家电信巨头,几十年来一直是股息投资组合中的主打产品。尽管面临市场挑战,AT&T仍坚持致力于为股东创造价值。该公司提供具有吸引力的股息收益率,这对以收入为中心的投资者尤其具有吸引力。鉴于其服务的基本性质,AT&T的收入来源相对稳定,有助于其维持股息支付的能力。 Procter & Gamble是消费品领域的领导者,是寻求股息的退休人士的另一个绝佳选择。Procter & Gamble以其广泛的家用产品而闻名,并以其可靠性和创新性而建立了声誉。该公司不断增加其股息支付,反映了其强劲的财务表现和对股东的承诺。随着消费者对必需品的需求保持稳定,Procter & Gamble有能力继续其股息增长轨迹。 AT&T和Procter & Gamble都体现了股息投资者所寻求的品质:稳定性、持续的表现以及与投资者分享利润的承诺。虽然没有哪项投资没有风险,但这些公司的过往记录为那些寻求可靠退休收入的人提供了一定程度的信心。 总之,寻求可靠收入来源的退休人士应考虑将AT&T和Procter & Gamble纳入其投资组合。这些公司不仅提供可靠的股息,还具有长期增长的潜力,使其成为任何退休策略的宝贵资产。 脚注: 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 尽管面临市场挑战,AT&T仍继续优先考虑股东回报。. Procter & Gamble在持续股息增长方面享有盛誉。. ```

General Motors 2025年第三季度财报概览

(SeaPRwire) -   General Motors (NYSE:GM) 公布了其2025年第三季度财报,展示了在复杂市场格局下的成就与挑战。这家汽车巨头在动荡的一年中,经历了消费者需求波动和向电动汽车持续转变的局面。尽管面临这些挑战,GM仍实现了380亿美元的收入,较上一季度略有增长。 该公司对电动汽车(EVs)的推进仍是焦点,在电动汽车生产和基础设施方面进行了大量投资。GM的首席执行官强调了他们对可持续性和创新的承诺,表示向电动汽车的转型不仅仅是一种趋势,更是未来交通发展的必然演变。本季度,GM推出了两款新型电动汽车,受到了消费者和行业专家的积极反馈。 然而,由于供应链中断和材料成本上涨,该公司正面临逆风,影响了其利润率。半导体短缺是影响整个汽车行业的关键问题,持续带来重大挑战。GM一直与供应商密切合作以缓解这些问题,但其财务业绩中仍能看出影响。 在市场表现方面,GM的股价在过去一个季度经历了波动。投资者正密切关注该公司应对当前经济状况并兑现增加电动汽车产量承诺的能力。股价反映了市场对GM战略举措及其克服现有障碍能力的预期。 GM的战略伙伴关系和合作是其增长战略的另一个关键方面。该公司最近宣布与一家领先的电池技术公司建立合作关系,以提高其电动汽车电池的效率和寿命。预计这项合作将在GM引领电动汽车市场的长期计划中发挥重要作用。 展望未来,GM对其前景持乐观态度。该公司计划提高其生产能力并扩大其电动汽车产品线,旨在在蓬勃发展的电动汽车领域中占据更大的市场份额。这些举措的成功对于GM努力保持其在汽车行业的领导地位至关重要。 总而言之,General Motors的第三季度业绩反映了该公司正处于转型期,在平衡传统汽车业务的同时,也在电动汽车领域设定了雄心勃勃的目标。挑战是巨大的,但GM的战略举措和对创新的关注使其为未来的增长和成功奠定了良好基础。 脚注: 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 General Motors报告其2025年第三季度财报,显示收入较上一季度略有增长。 半导体短缺继续影响GM的利润率,这是整个汽车行业的普遍问题。

Indonesia’s Legacy in the Global Vaccine Landscape: Bio Farma and DCVMN Strengthen Health Resilience through Global Partnership

BANDUNG, INDONESIA, Oct 21, 2025 - (ACN Newswire via SeaPRwire.com) - Through PT Bio Farma (Persero), Indonesia has played a strategic and sustained role in the Developing Countries Vaccine Manufacturers' Network (DCVMN), working to ensure equitable access to safe, high-quality, and affordable vaccines. Since DCVMN's founding in 2000, Bio Farma has been a key driver in advancing vaccine self-reliance and public health capacity in developing countries.Collaboration between Bio Farma and DCVMN has been established since the inception of the network. At the first DCVMN Annual General Meeting in Noordwijk in 2000, Bio Farma was one of ten founding members dedicated to advancing vaccine collaboration. In April 2001, Bio Farma in Bandung hosted the 2nd AGM, where the network formalized the DCVMN's structure and governance. Chaired by then-President Director Thamrin Poeloengan, this meeting established Indonesia as a hub for vaccine collaboration and knowledge-sharing among developing countries.Shadiq Akasya, current President Director of Bio Farma, stated that the company's participation in DCVMN reflects Indonesia's commitment to contributing to global health beyond national interests."Bio Farma's involvement in DCVMN since its establishment is not merely about representation, but about making a tangible contribution toward global vaccine self-reliance. Through collaboration and innovation, we are committed to delivering equitable and sustainable health solutions for all," said Shadiq."We believe that the true strength of the developing countries' vaccine industry lies in collaboration. Through our active role in DCVMN, we aim to ensure that every nation has access to safe, high-quality, and affordable vaccines, a real manifestation of Indonesia's contribution to global health security," he added.In 2004, Bio Farma, together with other DCVMN members, played a vital role in expanding access to the pentavalent (DPT-HepB-Hib) vaccine through a technology-transfer collaboration with the Netherlands Vaccine Institute. This achievement demonstrated that Bio Farma's contributions within the DCVMN network are not symbolic but deeply technical and practical.Global trust in Bio Farma has continued to grow. In 2012, Indonesia once again hosted the 13th DCVMN AGM in Bali. Mahendra Suhardono, one of Bio Farma's directors at the time, was elected President of the Executive Committee for the 2013 - 2014 term.Indonesia's leadership was further recognized when Bio Farma was entrusted to serve as Chair of the Board of DCVMN for the 2023-2025 period, acting as a bridge between network members and global strategic priorities, while showcasing Indonesia's capacity to lead the vaccine industry in developing countries.Bio Farma's commitment to innovation goes far beyond collaboration. In 2020, its nOPV2 vaccine became the first to receive an Emergency Use Listing from the World Health Organization, enabling faster deployment of vaccines during global health emergencies. This achievement reflected not only Bio Farma's scientific and technical excellence but also effective coordination and communication among multiple international stakeholders, including funders, scientists, academic researchers, policymakers, global vaccine advocates, and vaccine manufacturers. Such collaboration enabled the rapid development, approval, and rollout of nOPV2 during a critical moment for global public health.This milestone demonstrated that a developing-country manufacturer can achieve world-class innovation, meeting the highest international standards of safety, quality, and efficacy recognized by the WHO. Beyond being a scientific breakthrough, nOPV2 represents technological self-reliance and global confidence in Indonesia's capability to contribute meaningfully to international health security. Bio Farma's success serves as an inspiration to all DCVMN members to continue strengthening their research, development, and production capacity in pursuit of achieving vaccine self-sufficiency and global health resilience across developing countries.With a production capacity of more than 3.5 billion doses per year, Bio Farma supplies vaccines to over 150 countries and holds WHO Prequalification certification for 12 types of vaccines. As the Center of Excellence for the Organization of Islamic Cooperation (OIC) in vaccine development, production, and distribution, Bio Farma continues to strengthen Indonesia's strategic role in the global health landscape.The upcoming 26th DCVMN Annual General Meeting, to be held in Bali on 29–31 October 2025, marks an important moment for Indonesia to reaffirm its leadership in global health diplomacy. Through this forum, Bio Farma is committed to advancing innovation, collaboration, and vaccine self-reliance worldwide, toward a more resilient and equitable global health ecosystem.About DCVMNThe Developing Countries Vaccine Manufacturers Network (DCVMN) is a global alliance of 46 vaccine manufacturers from 17 developing countries, established in 2000 to strengthen public health through equitable access to high-quality vaccines.DCVMN promotes collaboration among its members through advocacy, capacity building, professional training, and joint research initiatives, aimed at enhancing global immunization programs.Working closely with international organizations such as WHO, UNICEF, GAVI, CEPI, PATH, CHAI, and the Gates Foundation, DCVMN strives to ensure that every nation has the capability to produce and supply affordable, life-saving vaccines. For further information, please visit www.dcvmn.org.About Bio FarmaPT Bio Farma (Persero) is Indonesia's state-owned life science company and the largest vaccine manufacturer in Southeast Asia.Founded in 1890 and headquartered in Bandung, Bio Farma produces and supplies vaccines to more than 150 countries, while playing an active role in biotechnology research, innovation, and global health security.As a member of DCVMN, Bio Farma continues to contribute to international collaboration to ensure equitable vaccine access and improved global public health. For further information, please visit www.biofarma.co.id.Contact UsPT Bio Farma (Persero)Corporate CommunicationJl. Pasteur No.28 Bandung,Jawa Barat Indonesia 40161Website: www.biofarma.co.idEmail: corcom@biofarma.co.id DCVMNRoute de Crassier, 7CH-1262 Nyon, SwitzerlandWebsite: www.dcvmn.org Email: info@dcvmn.net  Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

Indonesia’s Legacy in the Global Vaccine Landscape: Bio Farma and DCVMN Strengthen Health Resilience through Global Partnership

BANDUNG, INDONESIA, Oct 21, 2025 - (ACN Newswire via SeaPRwire.com) - Through PT Bio Farma (Persero), Indonesia has played a strategic and sustained role in the Developing Countries Vaccine Manufacturers' Network (DCVMN), working to ensure equitable access to safe, high-quality, and affordable vaccines. Since DCVMN's founding in 2000, Bio Farma has been a key driver in advancing vaccine self-reliance and public health capacity in developing countries.Collaboration between Bio Farma and DCVMN has been established since the inception of the network. At the first DCVMN Annual General Meeting in Noordwijk in 2000, Bio Farma was one of ten founding members dedicated to advancing vaccine collaboration. In April 2001, Bio Farma in Bandung hosted the 2nd AGM, where the network formalized the DCVMN's structure and governance. Chaired by then-President Director Thamrin Poeloengan, this meeting established Indonesia as a hub for vaccine collaboration and knowledge-sharing among developing countries.Shadiq Akasya, current President Director of Bio Farma, stated that the company's participation in DCVMN reflects Indonesia's commitment to contributing to global health beyond national interests."Bio Farma's involvement in DCVMN since its establishment is not merely about representation, but about making a tangible contribution toward global vaccine self-reliance. Through collaboration and innovation, we are committed to delivering equitable and sustainable health solutions for all," said Shadiq."We believe that the true strength of the developing countries' vaccine industry lies in collaboration. Through our active role in DCVMN, we aim to ensure that every nation has access to safe, high-quality, and affordable vaccines, a real manifestation of Indonesia's contribution to global health security," he added.In 2004, Bio Farma, together with other DCVMN members, played a vital role in expanding access to the pentavalent (DPT-HepB-Hib) vaccine through a technology-transfer collaboration with the Netherlands Vaccine Institute. This achievement demonstrated that Bio Farma's contributions within the DCVMN network are not symbolic but deeply technical and practical.Global trust in Bio Farma has continued to grow. In 2012, Indonesia once again hosted the 13th DCVMN AGM in Bali. Mahendra Suhardono, one of Bio Farma's directors at the time, was elected President of the Executive Committee for the 2013 - 2014 term.Indonesia's leadership was further recognized when Bio Farma was entrusted to serve as Chair of the Board of DCVMN for the 2023-2025 period, acting as a bridge between network members and global strategic priorities, while showcasing Indonesia's capacity to lead the vaccine industry in developing countries.Bio Farma's commitment to innovation goes far beyond collaboration. In 2020, its nOPV2 vaccine became the first to receive an Emergency Use Listing from the World Health Organization, enabling faster deployment of vaccines during global health emergencies. This achievement reflected not only Bio Farma's scientific and technical excellence but also effective coordination and communication among multiple international stakeholders, including funders, scientists, academic researchers, policymakers, global vaccine advocates, and vaccine manufacturers. Such collaboration enabled the rapid development, approval, and rollout of nOPV2 during a critical moment for global public health.This milestone demonstrated that a developing-country manufacturer can achieve world-class innovation, meeting the highest international standards of safety, quality, and efficacy recognized by the WHO. Beyond being a scientific breakthrough, nOPV2 represents technological self-reliance and global confidence in Indonesia's capability to contribute meaningfully to international health security. Bio Farma's success serves as an inspiration to all DCVMN members to continue strengthening their research, development, and production capacity in pursuit of achieving vaccine self-sufficiency and global health resilience across developing countries.With a production capacity of more than 3.5 billion doses per year, Bio Farma supplies vaccines to over 150 countries and holds WHO Prequalification certification for 12 types of vaccines. As the Center of Excellence for the Organization of Islamic Cooperation (OIC) in vaccine development, production, and distribution, Bio Farma continues to strengthen Indonesia's strategic role in the global health landscape.The upcoming 26th DCVMN Annual General Meeting, to be held in Bali on 29–31 October 2025, marks an important moment for Indonesia to reaffirm its leadership in global health diplomacy. Through this forum, Bio Farma is committed to advancing innovation, collaboration, and vaccine self-reliance worldwide, toward a more resilient and equitable global health ecosystem.About DCVMNThe Developing Countries Vaccine Manufacturers Network (DCVMN) is a global alliance of 46 vaccine manufacturers from 17 developing countries, established in 2000 to strengthen public health through equitable access to high-quality vaccines.DCVMN promotes collaboration among its members through advocacy, capacity building, professional training, and joint research initiatives, aimed at enhancing global immunization programs.Working closely with international organizations such as WHO, UNICEF, GAVI, CEPI, PATH, CHAI, and the Gates Foundation, DCVMN strives to ensure that every nation has the capability to produce and supply affordable, life-saving vaccines. For further information, please visit www.dcvmn.org.About Bio FarmaPT Bio Farma (Persero) is Indonesia's state-owned life science company and the largest vaccine manufacturer in Southeast Asia.Founded in 1890 and headquartered in Bandung, Bio Farma produces and supplies vaccines to more than 150 countries, while playing an active role in biotechnology research, innovation, and global health security.As a member of DCVMN, Bio Farma continues to contribute to international collaboration to ensure equitable vaccine access and improved global public health. For further information, please visit www.biofarma.co.id.Contact UsPT Bio Farma (Persero)Corporate CommunicationJl. Pasteur No.28 Bandung,Jawa Barat Indonesia 40161Website: www.biofarma.co.idEmail: corcom@biofarma.co.id DCVMNRoute de Crassier, 7CH-1262 Nyon, SwitzerlandWebsite: www.dcvmn.org Email: info@dcvmn.net  Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Tradelink and Fadada Sign Strategic Agreement to Promote Secure Cross-Border Digital Signing Solutions in Hong Kong

HONG KONG, Oct 21, 2025 - (ACN Newswire via SeaPRwire.com) – Tradelink Electronic Commerce Limited (“Tradelink”), a leading digital service provider in Hong Kong and Fadada Intelligence (Hong Kong) Limited (“Fadada”), a global provider of electronic signature, are pleased to announce a strategic partnership. Under this collaboration, Tradelink will serve as the exclusive distributor of Fadada’s global signing platform, Nota Sign, in Hong Kong, focusing on local customer needs and jointly promoting the adoption of digital signing services in the region. Additionally, the two parties will integrate their systems via Tradelink’s T+ digital platform to address efficiency and compliance challenges in cross-border document signing for both individuals and corporations.This partnership delivers value across two core dimensions: On one hand, Nota Sign will integrate Tradelink’s trusted digital identity — iD-One (for individuals) and iCorp-One (for corporations) — supported by recognized certificates issued by Tradelink’s wholly owned subsidiary, Digi-Sign Certification Services Limited, the only recognized commercial certification authority in Hong Kong. Combined with remote signing capabilities, this enhances the compliance and security of Nota Sign in the Hong Kong and overseas markets, ensuring hassle-free signing for customers. On the other hand, the integration with the T+ platform will streamline the entire document “initiation–signing–management” process, enabling global enterprises to access a seamless cross-border e-signature experience without the need to build additional technical infrastructure.Fadada has been a leading player in the electronic signature field for over a decade, serving renowned companies such as Microsoft, DELL, SAP, AIRBUS, FedEx, and DHL. Its clients span industries including internet, finance, manufacturing, logistics, and healthcare. Nota Sign, Fadada’s global e-signature platform supports diverse scenarios such as HR management, supply chain collaboration, cross-border transactions, IP licensing, financial services, and medical. In terms of global legal compliance, Nota Sign aligns with multiple legal frameworks, including eIDAS, ESIGN, and ETO, supports certification from major global CA authorities, and enables localized identity verification across more than 100 countries and regions. On the data governance front, it complies with the EU’s GDPR and Hong Kong’s Personal Data (Privacy) Ordinance (PDPO), covering the entire data lifecycle from collection to transmission and storage, with regionalized data storage ensuring sovereignty and security. The platform also offers multi-level trusted signing capabilities, supporting SES, SES + eKYC, AES, and QES to meet various risk preferences.Mr. Tommy Yuen, S.B.S, Executive Director and Chief Executive Officer of Tradelink, remarked: "The partnership with Fadada marks a significant milestone in advancing cross-border digital document exchange. As Hong Kong continues to play its role as a super connector and super value-adder, Tradelink is proud to echo that mission by empowering enterprises to enter the Chinese Mainland market while extending their global reach."Mr. Huang Xiang, Founder & Chief Executive Officer of Fadada, commended: "We look forward to working with Tradelink to leverage resources across the Greater Bay Area. This collaboration not only brings quality digital signing services to Hong Kong enterprises but also contributes to positioning Hong Kong as a showcase for legal technology, enabling local businesses to access globally compliant, secure, efficient, and intelligent legal tech services."This partnership reflects the shared vision of both parties: leveraging Nota Sign’s product strengths and Tradelink’s trusted digital identity and authentication capabilities to drive innovation in cross-border digital signing, enhance global compliance management for enterprises, and meet the growing demand for secure, adaptable digital solutions in Hong Kong and the surrounding region.From left to right: Mr. Huang Xiang, Founder and Chief Executive Officer of Fadada, Mr. Tommy Yuen, S.B.S., Executive Director and Chief Executive Officer of TradelinkFrom left to right: Mr. Andrew Cheng, Executive Director and Chief Operations Officer of Tradelink, Mr. Tommy Yuen, S.B.S., Executive Director and Chief Executive Officer of Tradelink, Mr. Huang Xiang, Founder and Chief Executive Officer of Fadada, Ms. Sabrina Lin, Senior Vice President and Chief Operating Officer of FadadaAbout Tradelink Electronic Commerce LimitedEstablished in 1988 and listed in 2005, Tradelink (Stock Code: 536) is Hong Kong’s digital efficiency pioneer. Since 1997, the company has successfully brought the advantages of its e-solutions to tens of thousands of organisations. Tradelink has pioneered numerous innovative business technology applications in Hong Kong, including EDI, digital certificates, biometric ID and warehouse automation. In addition to offering expertise in supply chain, identity management and PayTech solutions, the company leads in the city’s business-to-government document compliance market. Tradelink customers span all industry sectors. The company has earned the trust of governments, multinationals, and small and medium businesses alike. Hong Kong-based organisations seeking to measurably benefit from greater digital efficiency have a reliable partner with Tradelink.For more information about Tradelink, please visit http://www.tradelink.com.hk.About Fadada Intelligence (Hong Kong) LimitedFadada has been deeply engaged in the field of electronic signatures for over a decade, serving more than 100,000 enterprise clients worldwide across diverse industries, including internet, finance, manufacturing, consumer goods, logistics and transportation, real estate and construction, healthcare, human resources, government, and public services. Nota Sign, developed by Fadada, is a global electronic signature platform that strictly complies with electronic signature, data security, and privacy protection laws and regulations in major countries and regions around the world. It supports legal and regulatory requirements in over 100 countries and regions globally. Fadada is committed to building a trusted global e-signature network that provides reliable, intelligent, and convenient electronic signing services for businesses and individuals worldwide.For more information about Nota Sign, please visit https://www.notasign.com/zh-HK. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

贸易通与法大大签署战略合作协议 推动香港跨境合规电子签署解决方案

香港, 2025年10月21日 - (亚太商訊) - 香港数字服务领域代表企业贸易通电子贸易有限公司("贸易通")及全球电子签名产品与解决方案提供商Fadada Intelligence (Hong Kong) Limited("法大大")正式宣布双方达成战略合作。贸易通将作为法大大旗下全球签署平台 Nota Sign 在香港的独家经销商,聚焦香港客户需求,共同推动电子签服务在港落地。此外,双方将基于贸易通 T + 数字平台开展系统集成合作,进一步解决企业及个人跨境文档签署的效率与合规痛点。此次合作从两大核心维度释放价值:一方面,Nota Sign 通过整合贸易通的可信数字身份-iD-One(个人用户)和 iCorp-One(企业用户)(由贸易通全资附属公司、香港唯一获认可的商营核证机关-电子核证服务有限公司签发认可证书支持)及远程签名能力,进一步强化Nota Sign产品在香港及境外市场的合规性与安全性,切实保障客户签约无忧;另一方面,双方将基于 T+ 平台的深度对接优化文档"发起-签署-管理"全流程,让全球企业无需额外搭建技术架构,即可接入更便捷的跨境电子签体验。法大大深耕电子签名领域十余年,服务包括 Microsoft、DELL、SAP、AIRBUS、FedEx、DHL 在内的知名企业,客户遍布互联网、金融、制造、物流、医药医疗等行业。Nota Sign 全球签平台广泛适配人事管理、供应链协作、跨境交易、知识产权授权、金融服务、医药合作等多元场景:在全球法律合规保障上,平台适配 eIDAS、ESIGN、ETO 等多个国家 / 地区法律框架,支持全球主流 CA 机构认证与本地化身份核验,适配全球超 100 个国家及地区的法规要求;在全球数据安全治理层面,符合欧盟 GDPR、香港《个人资料(私隐)条例》(PDPO)等数据法规要求,覆盖数据采集、传输和存储全流程,通过区域化数据存储确保数据主权与安全;同时还提供多级合规可信签署能力,支持 SES、SES + eKYC、AES 和 QES,满足不同风险偏好的签署场景。贸易通执行董事及行政总裁袁民忠先生S.B.S.表示:"此次与法大大合作是推动跨境电子文件互换的重要里程碑。随着香港持续发挥超级联系人和超级增值人的角色,贸易通亦以协助企业'出海'与'入华'为己任,积极响应这一使命。"法大大创始人兼首席执行官黄翔先生表示:"我们期待与贸易通携手,联动大湾区资源,不仅为香港企业提供更优质的数字签约服务,更为香港打造法律科技示范高地贡献一份力,推动香港企业共享全球合规、安全、高效、智能的法律科技服务。"此次合作彰显了双方的共同愿景:依托 Nota Sign 全球签的产品优势与贸易通的本地可信数字身份及核证能力,推动跨境数字签约创新实践、强化企业全球合规管理能力,切实满足香港及区域内企业对安全合规、适配性强的跨境数字解决方案日益增长的需求。从左到右:法大大创始人兼首席执行官黄翔先生、贸易通执行董事兼行政总裁袁民忠先生S.B.S.从左到右:贸易通执行董事兼营运总监郑俊聪先生、贸易通执行董事兼行政总裁袁民忠先生S.B.S.、法大大创始人兼首席执行官黄翔先生、法大大高级副总裁兼首席运营官林希婧女士有关贸易通电子贸易有限公司贸易通(股份代号:536)于1988 年成立并于2005 年上市,是香港高效数码化的先驱者。自1997年以来,公司成功为香港数以万计的机构带来电子方案的优势。贸易通于香港开创多项崭新商业科技应用,包括电子数据联通、数码证书、生物认证及仓库自动化。除了提供供应链、身份管理和支付科技解决方案的专业知识之外,公司亦在企业对香港特区政府的合规文档市场具有领导地位。贸易通的客户遍及各行各业,赢得政府、跨国公司和中小企业的信任,与本地寻求借助高效数码 化得益的机构合作无间。更多关于贸易通详情,请浏览http://www.tradelink.com.hk。有关Fadada Intelligence (Hong Kong) Limited法大大深耕电子签名领域十余年,服务全球超10万家企业客户,覆盖互联网、金融、制造、消费、物流运输、地产建筑、医药医疗、人力资源、政务、公共服务等各行各业。Nota Sign全球签是法大大推出的全球化电子签平台,严格遵循全球主流国家与地区的电子签名、数据安全与隐私保护相关法律法规,适配全球超100个国家及地区的法规要求。法大大致力搭建覆盖全球的可信电子签约网络,为全球企业及个人提供可靠、智能和便捷的电子签名服务。更多关于Nota Sign详情,请浏览 https://www.notasign.com/zh-HK。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

GYMD Showcases Industrial AI and Digitalization Strength at Tech Week Singapore 2025

SINGAPORE, Oct 21, 2025 - (ACN Newswire via SeaPRwire.com) - Tech Week Singapore 2025 was successfully held at the Sands Expo and Convention Centre from October 8 to 9. As one of the featured exhibitors, GYMD Digital Technology( http://www.geega.com.en ). drew significant attention with its industrial digitalization and AI solutions, attracting a steady flow of visitors to its booth.Throughout the exhibition, GYMD engaged with professionals from the manufacturing, artificial intelligence, logistics, and supply chain sectors worldwide. Visitors showed strong interest in the company’s latest achievements in industrial software and industrial AI applications, particularly in digital production management and data-driven factory operations.GYMD’s on-site team delivered systematic demonstrations showcasing practical application scenarios and tangible business value. The team also held in-depth discussions with customers on industry practices and emerging technology trends, generating lively interaction and positive feedback throughout the event.Rooted in Manufacturing, Expanding Across the Industrial Value ChainOriginating in the automotive industry, GYMD has developed a deep understanding of industrial operations and successfully integrated digital technologies with domain expertise. Its solutions, derived from real-world automotive production practices, now serve industries such as automotive, new energy, and electronics manufacturing. The company provides intelligent services covering the entire value chain from R&D and production to supply, sales, and after-sales.To date, GYMD’s solutions have been successfully deployed in nearly 60 smart factories across more than 40 cities worldwide. Its operations have expanded from China to global markets. By leveraging its unified industrial platform, the company helps enterprises transform from isolated digital applications to fully intelligent operations, enabling shorter R&D cycles, lower defect rates, and improvements in overall manufacturing efficiency and competitiveness.Empowering Global Practices and Building Localized Digital EcosystemsWith proven implementation capabilities, GYMD is accelerating its strategic expansion.In 2024, GYMD began systematically empowering Agytek, its joint venture in Malaysia, by transferring mature digital transformation expertise and building a professional team. By aligning its solutions with local industrial strengths and market needs, GYMD is helping Agytek create a localized and sustainable digital ecosystem.At the Proton Super Factory, GYMD implemented digital solutions that enhanced operational efficiency and set a new benchmark for intelligent manufacturing. The company developed a digital factory system characterized by flexibility, agility, intelligence, and transparency, offering end-to-end services across the automotive lifecycle, including R&D, intelligent manufacturing, logistics, and digital marketing.Today, GYMD’s international business network spans 14 countries worldwide. During Tech Week Singapore, the company received partnership interest from enterprises in Singapore, Indonesia, Malaysia, Thailand, India, Vietnam, and other regions, demonstrating growing global momentum.Through this exhibition, GYMD not only showcased its technological strength but also broadened its international vision and reinforced its commitment to advancing global digital transformation. Looking ahead, the company will continue to build on its strong manufacturing foundation to deliver high-quality, practical, and scalable solutions that drive intelligent industrial upgrades around the world.Company: GYMD Digital Technology Co., Ltd.Contact Person: DavidEmail: geega-bm@geely.com Website: https://www.geega.com/en/ Telephone: 15510031213City: chongqing Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

战略视野:颖通控股(6883.HK)引入皇室香氛Trudon 强强联手抢占中国”嗅觉经济”制高点

香港, 2025年10月21日 - (亚太商訊) - 真正的行业领导者,总能于巨变中洞察新机。中国领先的全渠道香氛与美妆集团——颖通控股(06883.HK),秉持前瞻战略眼光,引入拥有近四百年皇室传承的法国奢侈香氛品牌Cire Trudon(Trudon),并成为其在中国内地、香港及澳门的独家代理,全面拓展其于大中华市场的布局。随着"情绪消费"浪潮兴起,现代消费者对香氛产品在情感疗愈和生活仪式感上的需求愈加明显,高端家居香氛正逐渐成为都市精英表达自我、提升幸福感的重要载体。此举不仅巩固颖通于亚洲高端市场的领导地位,更精准切入中国"嗅觉经济"的黄金赛道,为品牌组合注入新元素与长远价值。精准布局:数据背后的结构性红利颖通在消费周期波动之际选择逆势强化高端布局,并非偶然。据Frost & Sullivan及德勤预测,中国香氛市场将于2028年达477亿元人民币,其中家居香氛类别的年复合增长率高达18.1%,成为少数持续增长的高端板块。在消费结构重塑下,越来越多消费者愿为能彰显品味与品质的"小奢侈时刻"买单。Trudon凭借悠久皇室血统与工艺传承,正是这场"情感消费"浪潮的代表。而颖通的先机入局,展示其对市场脉动的敏锐洞察与精准判断。强强联手:顶级品牌遇上顶级渠道Trudon作为法国历史最悠久的香氛品牌,自1643年起便为法国皇室御用,其品牌价值早已深入全球奢侈品文化版图。其渠道覆盖巴黎、伦敦、纽约等世界级商圈,并进驻Le Bon Marché、Harrods、Net‑a‑Porter及SSENSE等高端零售体系。在中国大陆,Trudon进驻北京SKP、上海连卡佛等顶级百货与商场,同时登陆天猫国际、小红书等主流线上平台;在香港,则于连卡佛等精选百货与买手店均有陈列,品牌影响力遍及大中华核心高端消费圈层。Trudon选择颖通,不仅因后者具备领先的全渠道布局,更因颖通四十余年对中国市场的深刻理解与品牌精准运营能力。集团网络覆盖超过400座城市与8,000个销售终端,完美实现从线上到线下的立体渗透。这场"顶级品牌 × 顶级渠道"的强强联盟,成为Trudon在华成功的关键,也是颖通核心竞争力的最佳体现——能引进顶级品牌,更能让品牌成功落地、实现增值。资本肯定:国际机构高度认可颖通的战略节奏亦获得资本市场的权威肯定。里昂证券最新报告将颖通列为"首选股",指出颖通凭借聚焦高端市场与品牌协作策略,展现出卓越的经营韧性与超预期的盈利潜力。这份认可,进一步印证了颖通透过品牌升级与盈利结构优化所释放的长期价值。展望未来:共创香氛新纪元颖通控股已规划于2026年在香港开设首家香氛体验旗舰店,打造融合艺术、文化与生活的沉浸式品牌地标。Trudon将藉此成为大中华区见证欧式香氛艺术的核心舞台,同时带动集团旗下品牌的整体曝光与品牌资产升级。颖通与Trudon的合作,象征两大行业巨擘的同频共振,开启亚洲奢侈香氛市场的新篇章。在中国"嗅觉经济"快速崛起的浪潮中,颖通凭借稳健基础与卓越战略执行力,正迈向更具国际影响力的未来。对投资者而言,这场联手不仅是一段品牌故事,更是一个正在形成的增长奇迹。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Olympus: “Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India” Selected for METI’s FY2024 Supplementary “Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration / Feasibility Study Project)”

TOKYO, Oct 21, 2025 - (JCN Newswire via SeaPRwire.com) - Olympus Corporation (Olympus), today announced that the feasibility study project entitled “Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India,” jointly proposed with Saraya Co., Ltd. (hereinafter “SARAYA”), has been selected by the Ministry of Economy, Trade and Industry (METI) under its FY2024 supplementary “Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration/Feasibility Study Project)” on August 1, 2025.The selected feasibility study project (hereinafter the “Project”), supported by METI, will evaluate the feasibility of introducing Japan’s established infection control systems to India, aiming to enhance the safety and reliability of the endoscopic medical environment.In India, endoscopic procedures already outnumber those in Japan and are expected to grow further due to the country’s large and expanding population. However, compared to Japan, infection control systems are still evolving in terms of both technology and operational processes. For instance, many medical institutions still rely on manual cleaning methods although awareness and adoption of automated endoscope reprocessors are gradually increasing. In contrast, Japan has established rigorous academic guidelines and widely adopted digital endoscope reprocessing systems that minimize human error and ensure high standards of infection control.The Project, in collaboration with the Department of Infection Control and Prevention and the Department of Gastroenterology at the University of Tokyo Hospital, will investigate the feasibility of transferring Japan’s endoscopic infection control system to India. Medical experts from Indian medical institutions will be invited to Japan, where training and site visits at the University of Tokyo Hospital will help deepen their understanding of the Japanese infection control system. In parallel, experts from the University of Tokyo Hospital will visit medical institutions in India to assess the environment of endoscopy and reprocessing units, identify key challenges, and engage in discussions with Indian experts toward building a safer and more reliable endoscopic medical environment.Olympus has identified six focus areas, including “Healthcare Access and Outcome” and “Compliance, Product Quality and Safety.” Initiatives that deliver training and skill development opportunities for healthcare professionals, and ensure the quality and safety of products, services, and solutions are a top priority. Olympus remains committed to protecting the safety of patients and healthcare professionals, while leveraging Japanese technology to advance global medical standards.About Saraya Co., Ltd.SARAYA is committed to creating a prosperous and sustainable global society under the three core pillars of “Hygiene,” “Environment,” and “Health.” Since its founding in 1952, SARAYA has developed and delivered a wide range of products and services, from detergents and disinfectants to health foods, serving both professional and household markets.  https://saraya.world/ About OlympusAt Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global LinkedIn and X accounts.Media contact:Mail: Global-Public_Relations@olympus.com Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS] https://www.olympus-global.com   Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

VirPoint Announces Expansion of UK and European Operations, Demonstrating Its Leading Position in Digital Asset Strategy

LONDON, Oct 21, 2025 - (ACN Newswire via SeaPRwire.com) - VirPoint.com, a leading multi-asset trading platform, recently announced the expansion of its crypto and digital asset investment business in the UK and Europe. Under the leadership of Alexander Melnik, Senior Investment Specialist and Head of Crypto Desk, the crypto and digital asset investment division continues to perform strongly. This continued outperformance reflects VirPoint's ongoing commitment to delivering measurable value to clients through a combination of advanced analytics, AI-driven trading tools, and experienced human insight.In 2023, portfolios managed within VirPoint's Crypto Desk achieved average annual returns of 18.2%, exceeding the company's overall performance average of 8.5%, as reported by Yahoo Finance. Select digital-asset strategies under the division generated returns of up to 27%, highlighting the platform's success in integrating blockchain-based investments with traditional CFD and equity frameworks."VirPoint's strength lies in our ability to merge institutional discipline with innovation," said a company spokesperson. "Under Melnik's direction, the Crypto Desk has become a model for how technology and expert strategy can work together to navigate volatility and capture long-term growth opportunities."The performance reinforces VirPoint's position as a trusted partner for Prime-tier and institutional clients seeking diversified exposure across global markets. By aligning advanced trading infrastructure with strategic portfolio management, VirPoint continues to deliver consistent outcomes in both traditional and emerging asset classes.Investment Philosophy: AI-Enhanced Human InsightMelnik is a vocal advocate for technology-assisted investing, describing himself as "a big fan of innovation when it serves human intelligence not replaces it." Within VirPoint's ecosystem, he has helped refine the AI-based tools that monitor market sentiment, volatility, and correlation risk. Clients receive personal guidance on setting up these features through one-on-one Zoom or phone sessions, where Melnik explains each metric and integrates it into their trading strategy.His risk-management philosophy follows two core frameworks used by top institutional desks:The Kelly Criterion Adaptation - optimizing position size relative to the probability of success to maximize long-term portfolio growth while controlling drawdowns.Value-at-Risk (VaR) Discipline - maintaining exposure within statistically defined loss thresholds, ensuring stability even during unexpected volatility.By blending these quantitative techniques with intuition built from years on trading floors, Melnik helps clients capture opportunities while safeguarding capital - what he calls "the art of growing without overreaching."In 2024, Alexander Melnik and his team were honored with the VirPoint Excellence Award for outstanding performance and deep client satisfaction. The prestigious award, now prominently displayed in the firm's headquarters, serves as a symbol of Melnik's lasting impact on client trust and results.Beyond the accolade, he is widely respected for his mentorship of new specialists within VirPoint, always emphasizing integrity, patience, and emotional intelligence as pillars of advisory excellence. His mentorship sessions consistently draw ambitious younger traders eager to learn to balance technical rigor with psychological resilience.Melnik also leads advanced internal training sessions focused on modern asset allocation principles, where he promotes his signature strategy of combining traditional investments with digital assets to improve overall portfolio performance. His approach to strategic reallocation within blockchain-linked instruments has helped clients achieve higher percentage returns while maintaining strong risk control, a philosophy that has since been adopted by several VirPoint advisors across the firm.Under his guidance, many junior advisors have doubled their client satisfaction scores and demonstrated marked improvements in portfolio stability across volatile markets.For Melnik, education is not a task - it's a philosophy. He believes clients should understand why they invest, not just where. His trademark line, repeated in countless client meetings, summarizes this mindset:"Education is the king. Don't ask yourself if this or if that choose this and that. In diversity and knowledge lies real stability."Looking Ahead: Join the VirPoint CommunityAs VirPoint.com continues to expand its presence across the UK and Europe, the firm is deepening its commitment to client education and empowerment. New investors are invited to join VirPoint's New Client Program, which includes a complimentary introductory Zoom session led by experienced specialists such as Alexander Melnik. These sessions cover platform navigation, strategy fundamentals, and effective use of VirPoint's AI tools - giving clients the confidence to trade smarter from the start.Prospective traders can register directly on VirPoint.com to open an account, explore the VirPoint Academy, and access free resources including tutorials, webinars, and market guides. Whether you are new to CFD trading or managing a diverse portfolio, VirPoint offers the tools, education, and expert support to help you take the next step in your financial journey.Media ContactVirPoint Communications TeamWebsite: https://virpoint.com Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com